Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis
- PMID: 12387654
- DOI: 10.1001/jama.288.16.2015
Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis
Abstract
Context: It has been suggested that total blood homocysteine concentrations are associated with the risk of ischemic heart disease (IHD) and stroke.
Objective: To assess the relationship of homocysteine concentrations with vascular disease risk.
Data sources: MEDLINE was searched for articles published from January 1966 to January 1999. Relevant studies were identified by systematic searches of the literature for all reported observational studies of associations between IHD or stroke risk and homocysteine concentrations. Additional studies were identified by a hand search of references of original articles or review articles and by personal communication with relevant investigators.
Study selection: Studies were included if they had data available by January 1999 on total blood homocysteine concentrations, sex, and age at event. Studies were excluded if they measured only blood concentrations of free homocysteine or of homocysteine after a methionine-loading test or if relevant clinical data were unavailable or incomplete.
Data extraction: Data from 30 prospective or retrospective studies involving a total of 5073 IHD events and 1113 stroke events were included in a meta-analysis of individual participant data, with allowance made for differences between studies, for confounding by known cardiovascular risk factors, and for regression dilution bias. Combined odds ratios (ORs) for the association of IHD and stroke with blood homocysteine concentrations were obtained by using conditional logistic regression.
Data synthesis: Stronger associations were observed in retrospective studies of homocysteine measured in blood collected after the onset of disease than in prospective studies among individuals who had no history of cardiovascular disease when blood was collected. After adjustment for known cardiovascular risk factors and regression dilution bias in the prospective studies, a 25% lower usual (corrected for regression dilution bias) homocysteine level (about 3 micromol/L [0.41 mg/L]) was associated with an 11% (OR, 0.89; 95% confidence interval [CI], 0.83-0.96) lower IHD risk and 19% (OR, 0.81; 95% CI, 0.69-0.95) lower stroke risk.
Conclusions: This meta-analysis of observational studies suggests that elevated homocysteine is at most a modest independent predictor of IHD and stroke risk in healthy populations. Studies of the impact on disease risk of genetic variants that affect blood homocysteine concentrations will help determine whether homocysteine is causally related to vascular disease, as may large randomized trials of the effects on IHD and stroke of vitamin supplementation to lower blood homocysteine concentrations.
Comment in
-
Homocysteine and coronary heart disease: how great is the hazard?JAMA. 2002 Oct 23-30;288(16):2042-3. doi: 10.1001/jama.288.16.2042. JAMA. 2002. PMID: 12387658 No abstract available.
-
Review: elevated homocysteine levels are modestly associated with increased ischemic heart disease and stroke risk.ACP J Club. 2003 May-Jun;138(3):78. ACP J Club. 2003. PMID: 12725633 No abstract available.
Similar articles
-
Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention.Arch Intern Med. 1998 Apr 27;158(8):862-7. doi: 10.1001/archinte.158.8.862. Arch Intern Med. 1998. PMID: 9570171
-
Homocysteine, renal function, and risk of cardiovascular disease.Kidney Int Suppl. 2003 May;(84):S131-3. doi: 10.1046/j.1523-1755.63.s84.7.x. Kidney Int Suppl. 2003. PMID: 12694328
-
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.JAMA. 2005 Oct 12;294(14):1799-809. doi: 10.1001/jama.294.14.1799. JAMA. 2005. PMID: 16219884
-
Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.Semin Thromb Hemost. 2000;26(3):341-8. doi: 10.1055/s-2000-8101. Semin Thromb Hemost. 2000. PMID: 11011852 Review.
-
Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia.Curr Opin Clin Nutr Metab Care. 2007 Jan;10(1):32-9. doi: 10.1097/MCO.0b013e328011aa71. Curr Opin Clin Nutr Metab Care. 2007. PMID: 17143052 Review.
Cited by
-
Hyperhomocysteinemia as a metabolic disorder parameter is independently associated with the severity of coronary heart disease.Saudi Med J. 2015 Jul;36(7):839-46. doi: 10.15537/smj.2015.7.11453. Saudi Med J. 2015. PMID: 26108589 Free PMC article.
-
Association Analysis of Gut Microbiota and Prognosis of Patients with Acute Ischemic Stroke in Basal Ganglia Region.Microorganisms. 2023 Oct 30;11(11):2667. doi: 10.3390/microorganisms11112667. Microorganisms. 2023. PMID: 38004679 Free PMC article.
-
The impact of potentially modifiable risk factors for stroke in a middle-income area of China: A case-control study.Front Public Health. 2022 Aug 19;10:815579. doi: 10.3389/fpubh.2022.815579. eCollection 2022. Front Public Health. 2022. PMID: 36062135 Free PMC article.
-
Paradoxical absence of a prothrombotic phenotype in a mouse model of severe hyperhomocysteinemia.Blood. 2012 Mar 29;119(13):3176-83. doi: 10.1182/blood-2011-09-380568. Epub 2011 Dec 20. Blood. 2012. PMID: 22186991 Free PMC article.
-
Assessment of pyridoxine and folate intake in migraine patients.Adv Biomed Res. 2016 Mar 16;5:47. doi: 10.4103/2277-9175.178800. eCollection 2016. Adv Biomed Res. 2016. PMID: 27110544 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical